NCT04978727 2026-03-05A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaChildren's Oncology GroupPhase 1 Active not recruiting35 enrolled